Total Payments
$6,072
2024 Payments
$35.53
Companies
41
Transactions
407
Medicare Patients
6,166
Medicare Billing
$341,801
Payment Breakdown by Category
Food & Beverage$5,931 (97.7%)
Education$140.80 (2.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,931 | 404 | 97.7% |
| Education | $140.80 | 3 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $828.39 | 56 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $721.34 | 56 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $660.58 | 50 | $0 (2023) |
| PFIZER INC. | $643.93 | 47 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $482.39 | 30 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $426.36 | 31 | $0 (2022) |
| Merck Sharp & Dohme LLC | $232.66 | 16 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $228.94 | 17 | $0 (2023) |
| BIOTRONIK INC. | $191.61 | 10 | $0 (2021) |
| Astellas Pharma US Inc | $173.88 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35.53 | 2 | Terumo Medical Corporation ($20.09) |
| 2023 | $222.02 | 14 | SANOFI-AVENTIS U.S. LLC ($34.89) |
| 2022 | $1,023 | 70 | E.R. Squibb & Sons, L.L.C. ($248.14) |
| 2021 | $927.35 | 57 | Janssen Pharmaceuticals, Inc ($164.46) |
| 2020 | $831.50 | 54 | Amgen Inc. ($135.36) |
| 2019 | $1,038 | 72 | Amgen Inc. ($181.27) |
| 2018 | $1,118 | 77 | Amgen Inc. ($164.90) |
| 2017 | $876.91 | 61 | Novartis Pharmaceuticals Corporation ($162.11) |
All Payment Transactions
407 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: DEVICES | ||||||
| 08/01/2024 | Terumo Medical Corporation | GLIDEWIRE (Device), OPTITORQUE, METACROSS OTW | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: LESION ACCESS | ||||||
| 04/19/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiology | ||||||
| 04/13/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Cardio-renal | ||||||
| 04/05/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/04/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| 03/22/2023 | CashFlow Solutions, LLC | LYMPHA PRESS OPTIMAL PLUS(US) BT (Device), PCD-51 731A (US) - WHITE, PCD-52 737A (US) WHITE | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Pneumatic Compressor | ||||||
| 03/09/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/23/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/15/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/08/2023 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: DIABETES | ||||||
| 01/24/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/18/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.02 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/16/2022 | Terumo Medical Corporation | TR BAND (Device), ANGIO-SEAL, GLIDESHEATH SLENDER | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: VASCULAR ACCESS | ||||||
| 12/14/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.56 | General |
| Category: Cardiovascular | ||||||
| 12/06/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/01/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Cardiology | ||||||
| 11/17/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/15/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.78 | General |
| Category: Cardiovascular | ||||||
| 11/10/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/09/2022 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.46 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,485 | 1,934 | $226,830 | $73,905 |
| 2022 | 14 | 1,409 | 2,067 | $216,785 | $94,569 |
| 2021 | 17 | 1,543 | 2,206 | $214,202 | $87,425 |
| 2020 | 19 | 1,729 | 2,562 | $230,308 | $85,902 |
Total Patients
6,166
Total Services
8,769
Medicare Billing
$341,801
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 381 | $69,362 | $27,341 | 39.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 99 | $25,663 | $8,915 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 86 | 95 | $19,103 | $6,934 | 36.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 182 | 184 | $20,875 | $6,481 | 31.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 44 | $15,530 | $5,754 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $8,440 | $2,725 | 32.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 312 | 463 | $20,835 | $2,701 | 13.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 45 | $9,669 | $2,693 | 27.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 42 | 43 | $4,205 | $1,870 | 44.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 40 | 83 | $4,482 | $1,577 | 35.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 240 | 256 | $12,390 | $1,555 | 12.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 32 | $4,000 | $1,433 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $3,048 | $1,105 | 36.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 42 | 42 | $1,930 | $656.41 | 34.0% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 29 | 40 | $1,520 | $557.28 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 12 | $1,978 | $498.10 | 25.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 43 | 44 | $2,008 | $454.94 | 22.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 12 | 14 | $1,036 | $339.02 | 32.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 14 | 14 | $756.00 | $315.42 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 275 | 482 | $87,724 | $43,725 | 49.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 55 | 133 | $23,791 | $10,405 | 43.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 55 | 59 | $20,580 | $8,762 | 42.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 193 | 196 | $9,344 | $6,848 | 73.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $12,696 | $5,244 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 80 | $10,000 | $5,061 | 50.6% |
About Dr. Samuel King, MD
Dr. Samuel King, MD is a Cardiovascular Disease healthcare provider based in Orangeburg, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295800613.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel King, MD has received a total of $6,072 in payments from pharmaceutical and medical device companies, with $35.53 received in 2024. These payments were reported across 407 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,931).
As a Medicare-enrolled provider, King has provided services to 6,166 Medicare beneficiaries, totaling 8,769 services with total Medicare billing of $341,801. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Orangeburg, SC
- Active Since 11/21/2006
- Last Updated 12/31/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1295800613
Products in Payments
- ELIQUIS (Drug) $1,281
- XARELTO (Drug) $660.58
- Repatha (Biological) $598.74
- ENTRESTO (Drug) $360.26
- MULTAQ (Drug) $276.57
- LifeVest (Device) $228.94
- VERQUVO (Drug) $220.22
- Corlanor (Drug) $219.65
- PRALUENT (Drug) $205.82
- PRADAXA (Drug) $111.37
- BRILINTA (Drug) $106.73
- PRALUENT ALIROCUMAB INJECTION (Biological) $84.52
- INJECTAFER (Drug) $83.15
- MitraClip System (Device) $76.05
- Bidil (Drug) $74.48
- CAMZYOS (Drug) $68.27
- LEQVIO (Drug) $66.10
- JARDIANCE (Drug) $62.45
- BioMonitor 2 (Device) $57.62
- NEXLETOL (Drug) $55.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Orangeburg
John Hutto, Md, MD
Cardiovascular Disease — Payments: $5,598
Cardiovascular Disease $5,598
Dr. Mark Krzyston, M.d, M.D
Cardiovascular Disease — Payments: $5,033
Cardiovascular Disease $5,033
John Fry, M.d, M.D
Cardiovascular Disease — Payments: $3,714
Cardiovascular Disease $3,714
George Castro, Md, MD
Cardiovascular Disease — Payments: $3,424
Cardiovascular Disease $3,424
James Wells, Md, MD
Cardiovascular Disease — Payments: $93.01
Cardiovascular Disease $93.01